Published in Immunology on May 01, 1980
Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells. Infect Immun (1990) 1.31
Surface Lyt phenotype of suppressor cells in C57BL/6 mice infected with Mycobacterium lepraemurium. Clin Exp Immunol (1983) 0.87
Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site. Clin Exp Immunol (1991) 0.78
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. J Exp Med (1975) 13.69
Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition. J Exp Med (1978) 6.29
Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J Exp Med (1975) 5.42
Regulation of cellular and humoral immune responses by T-cell subclasses. Cold Spring Harb Symp Quant Biol (1977) 5.21
T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells. J Exp Med (1976) 5.11
Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. J Exp Med (1977) 3.38
Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen. J Exp Med (1979) 3.35
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity. Eur J Immunol (1976) 2.36
The I-J subregion codes for determinats on suppressor factor(s) which limit the contact sensitivity response to picryl chloride. J Exp Med (1977) 2.07
Murine lymphocyte surface antigens. Adv Immunol (1979) 2.04
A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera. J Immunol Methods (1978) 1.91
Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Eur J Immunol (1978) 1.89
Suppression of IgE antibody production in SJL mice. II. Expression of Ly-1 antigen on helper and nonspecific suppressor T cells. J Immunol (1977) 1.40
The Ly phenotype of suppressor T cells arising in mice subjected to a graft-versus-host reaction. J Exp Med (1977) 1.35
Ly phenotype and mechanism of action of mouse neonatal suppressor T cells. J Exp Med (1977) 1.33
Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera. Cell Immunol (1977) 1.33
Appearance of non-specific suppressor T cells during in vitro culture. Immunology (1977) 1.21
Detection of mouse alloantibodies by rosetting with protein A-coated sheep red blood cells. Transplantation (1978) 1.05
Ly-4.2: a cell membrane alloantigen of murine B lymphocytes. I. Population studies. J Immunol (1975) 1.03
Adult murine T cells activated in vitro by alpha-fetoprotein and naturally occurring T cells in newborn mice: identity in function and cell surface differentiation antigens. Proc Natl Acad Sci U S A (1978) 0.93
Determination of lymphocyte division by flow cytometry. J Immunol Methods (1994) 11.48
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (1978) 6.59
A procedure for removing red cells and dead cells from lymphoid cell suspensions. J Immunol Methods (1975) 4.22
Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect Immun (1978) 3.24
New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods (1990) 3.19
Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med (1999) 3.06
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition. Acta Neuropathol (1984) 2.97
Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci U S A (1998) 2.71
Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant or susceptible mice. Infect Immun (1978) 2.65
T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63
Immune response to chemically modified flagellin. II. Evidence for a fundamental relationship between humoral and cell-mediated immunity. J Exp Med (1971) 2.47
The relationship between humoral and cell-mediated immunity. Transplant Rev (1972) 2.43
The B cell antigen receptor complex: association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. Science (1992) 2.41
Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity. Eur J Immunol (1976) 2.36
B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J Exp Med (1979) 2.28
T-T interactions in the induction of suppressor and helper T cells: analysis of membrane phenotype of precursor and amplifier cells. J Exp Med (1977) 2.22
Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med (1981) 2.18
Brain biochemistry in Williams syndrome: evidence for a role of the cerebellum in cognition? Neurology (1998) 2.09
Murine lymphocyte surface antigens. Adv Immunol (1979) 2.04
In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection. Cell Immunol (1982) 1.97
Adenovirus-induced alterations of the cell growth cycle: a requirement for expression of E1A but not of E1B. J Virol (1983) 1.93
A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera. J Immunol Methods (1978) 1.91
Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J Exp Med (1972) 1.90
Low zone tolerance to bacterial flagellin in adult rats: a possible role for antigen localized in lymphoid follicles. Proc Natl Acad Sci U S A (1968) 1.81
The role of beta 2-microglobulin in peptide binding by class I molecules. Science (1990) 1.80
The lymphocyte surface. I. Relation between Fc receptors, C'3 receptors and surface immunoglobulin. Proc R Soc Lond B Biol Sci (1974) 1.80
Inflammatory process in murine lymphocytic choriomeningitis is maximal in H-2K or H-2D compatible interactions. J Immunol (1976) 1.78
The lymphocyte surface. II. Separation of Fc receptor, C'3 receptor and surface immunoglobulin-bearing lymphocytes. Proc R Soc Lond B Biol Sci (1974) 1.76
Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci U S A (1993) 1.76
Preferential induction of cell-mediated immunity by chemically modified sheep erythrocytes. Eur J Immunol (1972) 1.73
Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med (1995) 1.70
Which T cells cause graft rejection? Transplantation (1982) 1.69
Listeria monocytogenes infects human endothelial cells by two distinct mechanisms. Infect Immun (1995) 1.68
Automated colorimetric assay for T cell cytotoxicity. J Immunol Methods (1983) 1.68
"B"-cell stimulation of allogeneic T-cell proliferation in mixed lymphocyte cultures. Nat New Biol (1973) 1.68
Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ (2009) 1.66
Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol (1992) 1.64
Immune response to chemically modified flagellin. I. Induction of antibody tolerance to flagellin by acetoacetylated derivatives of the protein. J Exp Med (1971) 1.60
Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule. Proc Natl Acad Sci U S A (1990) 1.59
MUC1 cross-reactive Gal alpha(1,3)Gal antibodies in humans switch immune responses from cellular to humoral. Nat Med (1998) 1.58
Mouse macrophage beta subunit (CD11b) cDNA for the CR3 complement receptor/Mac-1 antigen. Immunogenetics (1990) 1.58
Cleavage of bacterial flagellin with cyanogen bromide. Antigenic properties of the protein fragments. Biochem J (1969) 1.53
Separation and functional analysis of subpopulations of lymphocytes bearing complement and Fc receptors. Transplant Rev (1975) 1.53
Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J Immunother (2001) 1.52
Ir gene function in an I-A subregion mutant B6.C-H-2bm12. J Exp Med (1981) 1.51
Protein determination on an automatic spectrophotometer. Anal Biochem (1982) 1.50
Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a marine model of airway sensitization. J Exp Med (1996) 1.49
Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses. J Immunol (1980) 1.48
Tissue expression, structure and function of the murine Ly-6 family of molecules. Immunol Cell Biol (1995) 1.48
Detection and significance of occult metastases in node-negative breast cancer. Br J Surg (1993) 1.47
Peptide mimics of a tumor antigen induce functional cytotoxic T cells. Nat Biotechnol (1998) 1.46
The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology (1990) 1.45
A simple and rapid acrylamide gel method for estimating the molecular weights of proteins and protein subunits. Anal Biochem (1970) 1.44
Lesions in the blood supply of the papilla in experimental analgesic nephropathy. Med J Aust (1968) 1.42
Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J Immunol (1999) 1.41
Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res (1991) 1.41
Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis. Diabetologia (2008) 1.41
Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection. J Exp Med (1980) 1.41
Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J Clin Invest (1997) 1.40
Mitotic recombination between homologous chromosomes generates H-2 somatic cell variants in vitro. Proc Natl Acad Sci U S A (1987) 1.40
Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev (1994) 1.40
Mucins: structure, function, and associations with malignancy. Bioessays (1992) 1.40
Molecular cloning of a human immunoglobulin G Fc receptor. Proc Natl Acad Sci U S A (1988) 1.38
Identification of active-site residues of the pro-metastatic endoglycosidase heparanase. Biochemistry (2000) 1.37
Partial primary structure of the T4 antigens of mouse and sheep: assignment of intrachain disulfide bonds. Proc Natl Acad Sci U S A (1986) 1.36
Comparisons of ATP turnover in human muscle during ischemic and aerobic exercise using 31P magnetic resonance spectroscopy. Magn Reson Med (1994) 1.35
Monoclonal antibodies to the murine Ly-2.1 cell surface antigen. Immunology (1982) 1.35
Deposits of immunoglobulin and fibrin in human allografted kidneys. Lancet (1968) 1.35
Cleavage of bacterial flagellin with cyanogen bromide. Chemical and physical properties of the protein fragments. Biochem J (1969) 1.34
Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera. Cell Immunol (1977) 1.33
Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol Immunol (1993) 1.32
Ly-4, a new locus determining a lymphocyte cell-surface alloantigen in mice. Proc Natl Acad Sci U S A (1973) 1.30
Lack of a correlation between cell-mediated immunity to the carrier and the carrier-hapten helper effect. J Exp Med (1974) 1.30
Intracellular fluorescent labelling of cells for analysis of lymphocyte migration. J Immunol Methods (1984) 1.30
Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat Struct Biol (1999) 1.29
H-2 hemizygous mutants from a heterozygous cell line: role of mitotic recombination. EMBO J (1983) 1.28
Role of the mannose receptor in the immune response. Curr Mol Med (2001) 1.28
Th2-mediated anti-tumour immunity: friend or foe? Tissue Antigens (2007) 1.28
Identification and quantification of complement regulator CD46 on normal human tissues. Immunology (1993) 1.28
Antibody production in immunosuppressed recipients of renal allografts. Lancet (1969) 1.28
Cooperation between mouse T-cell subpopulations in the cell-mediated response to a natural poxvirus pathogen. Cell Immunol (1976) 1.26
The Lyt-2 molecule recognizes residues in the class I alpha 3 domain in allogeneic cytotoxic T cell responses. J Exp Med (1988) 1.26
A novel in vitro assay for human angiogenesis. Lab Invest (1996) 1.25
Regulation of the immune response by antibody. I. Suppression of antibody formation and concomitant enhancement of cell-mediated immunity by passive antibody. Cell Immunol (1972) 1.25
Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol (1993) 1.24
An improved colorimetric assay for T cell cytotoxicity in vitro. J Immunol Methods (1984) 1.24
Monoclonal antibodies reactive with mucin expressed in breast cancer. Immunol Cell Biol (1989) 1.23
Expression of H-2Db on the cell surface in the absence of detectable beta 2 microglobulin. J Exp Med (1984) 1.23
Cutaneous leishmaniasis in mice: disease patterns in reconstituted nude mice of several genotypes infected with Leishmania tropica. Aust J Exp Biol Med Sci (1980) 1.22
Tolerance in adult rats to a purified protein, flagellin, from Salmonella adelaide. Nature (1967) 1.22
Hu Ly-m5: a unique antigen physically associated with HLA molecules. Hum Immunol (1983) 1.22
Appearance of non-specific suppressor T cells during in vitro culture. Immunology (1977) 1.21
Arthroplasty of the knee in rheumatoid arthritis and osteoarthritis. A follow-up study after implantation of the McKeever and MacIntosh prostheses. J Bone Joint Surg Am (1972) 1.21
A genomic clone encoding the alpha chain of the OKM1, LFA-1, and platelet glycoprotein IIb-IIIa molecules. Proc Natl Acad Sci U S A (1986) 1.20
A new breast carcinoma antigen defined by a monoclonal antibody. J Natl Cancer Inst (1985) 1.20
Mutation in the IA subregion of the murine H-2 complex. Immunogenetics (1980) 1.20